Drugplain

ANTIPERSPIRANT ANTISUDORIFIQUE 12.4 mg/62mL

ANTIPERSPIRANT ANTISUDORIFIQUE · SPRAY · Archifox GmbH & Co. KG

No Recall History
Plain English

ANTIPERSPIRANT ANTISUDORIFIQUE is a spray containing antiperspirant antisudorifique at 12.4 mg/62mL, taken topical. Manufactured by Archifox GmbH & Co. KG.

Key Facts

Brand Name
ANTIPERSPIRANT ANTISUDORIFIQUE
Generic Name
ANTIPERSPIRANT ANTISUDORIFIQUE
NDC Code (Product)
84724-0002
Manufacturer
Archifox GmbH & Co. KG
Strength
12.4 mg/62mL
Dosage Form
SPRAY
Route
TOPICAL
Marketing Status
Marketing Start
12/01/2025

Recall History

No Recall History

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

For external use only. Do not use on broken skin. Stop use if rash or irritation occurs. ‘Aska doctor before use if you have kidney disease. Keep out of reach of children. If swallowed, get medical help or contact Poison Control Center.

Dosage & Administration

DIRECTIONS Underarm use only.

Warnings

Decreases excessive sweating.

Frequently Asked Questions

What is ANTIPERSPIRANT ANTISUDORIFIQUE used for?

ANTIPERSPIRANT ANTISUDORIFIQUE contains ANTIPERSPIRANT ANTISUDORIFIQUE. It is a spray taken topical. Consult your doctor for specific uses.

Is ANTIPERSPIRANT ANTISUDORIFIQUE a controlled substance?

ANTIPERSPIRANT ANTISUDORIFIQUE is not classified as a controlled substance by the DEA.

What is the generic name for ANTIPERSPIRANT ANTISUDORIFIQUE?

The generic name for ANTIPERSPIRANT ANTISUDORIFIQUE is ANTIPERSPIRANT ANTISUDORIFIQUE. There are 2 other brand versions of ANTIPERSPIRANT ANTISUDORIFIQUE.

What is the NDC code for ANTIPERSPIRANT ANTISUDORIFIQUE 12.4 mg/62mL?

The NDC (National Drug Code) for ANTIPERSPIRANT ANTISUDORIFIQUE 12.4 mg/62mL is 84724-0002, listed by Archifox GmbH & Co. KG.

Product NDC

84724-0002

Package NDC

84724-0002-1

Other ANTIPERSPIRANT ANTISUDORIFIQUE Dosages

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)